PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 3 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
The germacrane derivative DHGD significantly inhibited ear oedema in a dose-dependent manner (ID50 of 0.40 micromol/cm2) and showed higher inhibition of the oedematous response (61%) and granulocyte recruitment compared to an equimolar dose of indomethacin [PMID:11582545].
Evidence summary
PubMed sources
- 1.PMID: 11531084 (2001) — Flavon- and flavonolglycosides from Achillea pannonica Scheele. · Zeitschrift fur Naturforschung. C, Journal of biosciences
- 2.PMID: 12872918 (2003) — Sesquiterpenes from Achillea pannonica Scheele. · Zeitschrift fur Naturforschung. C, Journal of biosciences
- 3.PMID: 11582545 (2001) — Topical anti-inflammatory activity of a new germacrane derivative from Achillea pannonica. · Planta medica